Pathophysiological and Prognostic Importance of an ExtraCardiac Comorbidity Burden in Patients with Heart Failure with Preserved Ejection Fraction

心脏外合并症负担对射血分数保留型心力衰竭患者的病理生理学和预后意义

阅读:1

Abstract

BACKGROUND: Extracardiac comorbidities are highly prevalent in patients with heart failure with preserved ejection fraction (HFpEF). We investigated the pathophysiological contribution of an extracardiac comorbidity burden to cardiac function, exercise capacity, and prognosis in patients with HFpEF. METHODS: A total of 775 patients (372 HFpEF patients and 403 control subjects) underwent exercise echocardiography, with simultaneous expired gas analysis. We separated the previously validated Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) risk score into cardiac, extracardiac, and demographic categories. An Extracardiac burden was defined as an extracardiac domain score ≥ 5 (median value). RESULTS: Compared to control subjects (n = 403) and patients with HFpEF without an extracardiac burden (n = 185), patients with HFpEF with an extracardiac burden (n = 187) had higher natriuretic peptide levels and worse exercise capacity. They also had worse ventilatory efficiency and worse peripheral O(2) extraction during exercise. Kaplan-Meier analysis revealed that HFpEF patients with an extracardiac burden had a significantly higher risk of the composite outcome of all-cause mortality and worsening HF events than did those without this burden (log-rank P < 0.0001). Cox regression analysis showed that the extracardiac domain score was significantly associated with a higher risk of the composite events (P < 0.0001). In contrast, an extracardiac comorbidity burden was not associated with impaired exercise capacity, worse ventilatory efficiency, impaired peripheral O(2) extraction, or worse clinical outcomes in control subjects. CONCLUSIONS: An extracardiac comorbidity burden in patients with HFpEF is associated with relevant pathophysiological features characterized by impaired exercise capacity, worse ventilatory efficiency, impaired O(2) extraction and utilization in the periphery, and poor clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。